Neuronetics Inc (STIM)

Currency in USD
1.515
+0.165(+12.22%)
Closed·
STIM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.1951.520
52 wk Range
0.8005.130
Key Statistics
Prev. Close
1.35
Open
1.31
Day's Range
1.195-1.52
52 wk Range
0.8-5.13
Volume
3.7M
Average Volume (3m)
1.99M
1-Year Change
-69.7605%
Book Value / Share
0.33
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
STIM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.333
Upside
+186.03%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period

Neuronetics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Neuronetics Inc SWOT Analysis


Merger Momentum
Neuronetics' merger with Greenbrook TMS shows early success, with significant synergies realized and expanded market presence driving growth potential
Financial Resilience
Despite high Q1 cash burn, Neuronetics projects cash flow breakeven by Q3 2025 and maintains a healthy current ratio of 2.44
Strategic Expansion
SPRAVATO rollout and Brain Music Programming initiatives poised to boost revenue, with potential for adolescent indication coverage opening new markets
Market Outlook
Analysts set $7.00 price target, reflecting optimism in Neuronetics' growth trajectory amid competitive neurohealth solutions landscape
Read full SWOT analysis

Neuronetics Inc Earnings Call Summary for Q4/2025

  • Q4 revenue surged 86% YoY to $41.8M, beating estimates by 2.73%, driven primarily by Greenbrook acquisition integration.
  • EPS of -$0.10 missed forecast of -$0.09 by 11.11%; stock declined 5.74% premarket to $1.282 amid profitability concerns.
  • Gross margin compressed to 52% from 66% YoY; company achieved positive operating cash flow of $0.9M in Q4.
  • FY2026 guidance projects gross margins between 47-49%; ongoing criminal investigation into billing practices remains key risk factor.
  • Leadership transition underway with Dan Reuvers as incoming CEO; focus on operational efficiency and mental health clinic network expansion.
Last Updated: 17/03/2026, 13:30
Read Full Transcript

Compare STIM to Peers and Sector

Metrics to compare
STIM
Peers
Sector
Relationship
P/E Ratio
−2.4x−3.6x−0.5x
PEG Ratio
−0.04−0.060.00
Price/Book
4.2x6.5x2.6x
Price / LTM Sales
0.6x4.3x3.2x
Upside (Analyst Target)
123.9%44.7%53.4%
Fair Value Upside
Unlock2.0%7.7%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 4.333
(+186.03% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Canaccord
Buy3.00+98.02%7.00Maintain18/03/2026
Piper Sandler
Buy3.00+98.02%5.50Maintain17/03/2026
Stifel
Buy324.00+21,286.14%240.00Maintain18/09/2025
Canaccord Genuity
Buy7.00+362.05%8.00Maintain06/08/2025
Citizens JMP
Buy7.00+362.05%-Maintain28/07/2025

Earnings

Latest Release
17/03/2026
EPS / Forecast
-0.10 / -0.09
Revenue / Forecast
41.77M / 40.66M
EPS Revisions
Last 90 days

People Also Watch

2.42
ELPW
-19.66%
1.0200
JZXN
-0.97%
3.67
TLYS
+2.80%
2.180
AIFF
-2.24%
0.800
ALUR
+7.02%

FAQ

What Is the Neuronetics (STIM) Share Price Today?

The Neuronetics stock price today is 1.515 USD.

What Stock Exchange Does Neuronetics (STIM) Trade On?

Neuronetics is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Neuronetics?

The stock symbol (also called a 'ticker') for Neuronetics is "STIM."

What Is the Current Neuronetics Market Cap?

As of today, Neuronetics market cap is 99.410M USD.

What Is Neuronetics's (STIM) Earnings Per Share (TTM)?

The Neuronetics EPS is currently -0.591 (Trailing Twelve Months).

When Is the Next Neuronetics Earnings Date?

Neuronetics's next earnings report will be released on 12/05/2026.

Is STIM a Buy or Sell From a Technical Analyst Perspective?

Based on today's Neuronetics moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Neuronetics Stock Split?

Neuronetics has split 0 times. (See the STIM stock split history page for full effective split date and price information.)

How Many Employees Does Neuronetics Have?

Neuronetics has 658 employees.

What is the current trading status of Neuronetics (STIM)?

As of 19/03/2026, Neuronetics (STIM) is trading at a price of 1.515 USD, with a previous close of 1.350 USD. The stock has fluctuated within a day range of 1.195 USD to 1.520 USD, while its 52-week range spans from 0.800 USD to 5.130 USD.

What Is Neuronetics (STIM) Price Target According to Analysts?

The average 12-month price target for Neuronetics is 4.333 USD, with a high estimate of 7 USD and a low estimate of 3 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +186.03% Upside potential.

What Is the STIM Premarket Price?

STIM's last pre-market stock price is 1.310 USD. The pre-market share volume is 34,870.000, and the stock has decreased by -0.040, or -2.960%.

What Is the STIM After Hours Price?

STIM's last after hours stock price is 1.300 USD, the stock has decreased by -0.050, or -3.700%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.